Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia-Reference-Cited by-同舟云学术

Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia

Published:2010-11-29 Issue:50 Volume:107 Page:21824-21829
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Fasano S.,Bezard E.,D'Antoni A.,Francardo V.,Indrigo M.,Qin L.,Dovero S.,Cerovic M.,Cenci M. A.,Brambilla R.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference47 articles.

1. Molecular mechanisms of L-DOPA-induced dyskinesia

2. Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia

3. Molecular mechanisms underlying levodopa-induced dyskinesia

4. Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia

5. Is the Ras-MAPK signalling pathway necessary for long-term memory formation?

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-HT4R agonism reduces L-DOPA-induced dyskinesia via striatopallidal neurons in unilaterally 6-OHDA lesioned mice;Neurobiology of Disease;2024-08

2. A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease;Nature Medicine;2023-11

3. BDNF/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia;Neurobiology of Disease;2023-09

4. Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia;Antioxidants;2023-07-19

5. On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI–MS Imaging;Journal of the American Society for Mass Spectrometry;2023-04-13